Alcohol Use and T‐Lymphocyte Subsets among Injection Drug Users with HIV‐1 Infection: A Prospective Analysis
- 11 April 1996
- journal article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 20 (2) , 364-371
- https://doi.org/10.1111/j.1530-0277.1996.tb01654.x
Abstract
Objectives: Alcohol use is known to alter immune function and has immunosuppressive effects that may modify T-lymphocyte subpopulations. However, there is no clear evidence regarding the relationship of alcohol use with the progression of immunodeficiency in human immunodeficiency virus-type 1 (HIV-1)-seropositive individuals, particularly injection drug users (IDUs). Methods: Using prospective data from a cohort of IDUs in a study of the natural history of HIV infection, we examined the relationship of alcohol use and changes in T-lymphocyte subsets. Among the 2921 IDUs followed semiannually in outpatient clinics, 188 were documented HIV-1 seroconverters with known time of seroconversion. At each visit, all study participants were interviewed, underwent physical examinations, and had blood drawn for laboratory studies. Alcohol use was measured by reported frequency and quantity of alcoholic beverages. Longitudinal analyses included data for up to 5 years postseroconversion. To formally test the association of alcohol use with change in levels of CD4+ and CD8+ cells subsequent to HIV seroconversion, regression models incorporating autocorrelation structure were applied. Results: Alcohol use was not appreciably related to age, gender, marital status, income, education, or the duration of intravenous drug use. CD4% decreased for all IDUs within the first 5 years after seroconversion, with no significant differences between alcohol categories. CD8% increased for all IDUs, with no significant differences by alcohol category within the first 2 years after seroconversion. However, between 2 to 5 years postseroconversion, there was a statistically significant increase among the heaviest drinkers: CD8% increased 6.9%/year [95% confidence interval (CI): 4.7, 8.0] for the IDUs who reported Conclusions: In this study population of IDUs, CD8% (but not CD4%) is associated with alcohol consumption early after HIV seroconversion. This is the first prospective study to date to assess the relationship of alcohol use with HIV progression from the time of HIV seroconversion among a cohort of IDUs. If confirmed in future investigations, the findings may have significant implications for prevention and early intervention programs aimed at inhibiting disease progression among HIV-positive IDUs.Keywords
This publication has 42 references indexed in Scilit:
- Immunological parameters in current and former US Air Force personnelVaccine, 1993
- Ethanol inhibits mitogen-induced calcium mobilization in mouse splenocytesLife Sciences, 1992
- Flow Cytometric and Immunohistochemical Evaluation of Ethanol‐Induced Changes in Splenic and Thymic Lymphoid Cell PopulationsAlcohol, Clinical and Experimental Research, 1991
- Aids, drugs of abuse and the immune system: A complex immunotoxicological networkArchives of Toxicology, 1991
- The associations of race, cigarette smoking, and smoking cessation to measures of the immune system in middle-aged menClinical Immunology and Immunopathology, 1991
- Quality control in the flow cytometric measurement of T-lymphocyte subsets: The Multicenter AIDS Cohort Study experienceClinical Immunology and Immunopathology, 1990
- No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. A report from the Multicenter AIDS Cohort StudyJAMA, 1989
- Cocaine use and HIV infection in intravenous drug users in San FranciscoJAMA, 1989
- Changes in lymphocyte subsets and macrophage functions from high, short-term dietary ethanol in C57/BL6 miceLife Sciences, 1988
- Inhibition of natural killer cell activity in vitro by alcoholsBiochemical and Biophysical Research Communications, 1982